Prashant Chittiboina

19PUBLICATIONS
59CO-AUTHORS
NeurogeneticsCancer geneticsPredictive and prognostic markersMolecular targetsEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Aug 20, 2026
Germline NF2 variant position constrains somatic second hits and determines clinical severity in Neurofibromatosis Type 2-related schwannomatosis.

|Mar 09, 2026
Neurogenetic tumor syndromes: The current landscape of workup and treatment.

Rimas V Lukas, Ashley Cannon, Prashant Chittiboina

|Jan 07, 2026
Radiological Surveillance for Pituitary Adenomas in Multiple Endocrine Neoplasia Type 1: A Longitudinal Cohort Study.

Yetunde B Omotosho, Nayan U Vikram, Elizabeth C Wright

|Dec 31, 2025
Phosphoproteomic dysregulation drives tumor proliferation in Cushing's disease.

David T Asuzu, Dustin Mullaney, Debjani Mandal

|Nov 26, 2025
Variable Schwann cell merlin inactivation is targetable with TEAD1 inhibition in schwannomas.

Maxwell T Laws, Dhruval Bhatt, Debjani Mandal

|Sep 29, 2025
Basilar artery vasospasm following transsphenoidal resection of recurrent pituitary macroadenoma: illustrative case.

Luke R Jackson, Joshua Miles Diamond, Prashant Chittiboina

Pageof 4

Frequent Collaborators

4 joint publications

Christina Tatsi

3 joint publications

Zied Abdullaev

2 joint publications

Dragan Maric

2 joint publications

Reinier Alvarez